Middle East & Africa Embolization Devices Market Report (2021-2031) by Scope, Segmentation, Dynamics, and Competitive Analysis

The Middle East & Africa embolization devices market size is expected to reach US$ 162.93 million by 2031 from US$ 93.26 million in 2024. The market is estimated to record a CAGR of 8.3% from 2025 to 2031.

Executive Summary and Middle East & Africa Embolization Devices Market Analysis:

The embolization devices market in the Middle East & Africa is segmented into the UAE, Saudi Arabia, South Africa, and the Rest of Middle East & Africa. The regional market growth is attributed to technological advancements and developments by market players. Also, factors such as rising healthcare infrastructure, increasing prevalence of chronic conditions, supportive government plans, and growing strategic initiatives by market players boost the Middle East & Africa embolization devices market growth. Furthermore, the acceptance and integration of modern technologies drive the market growth in the region. Furthermore, increasing healthcare investments and infrastructure development in countries like the UAE and Saudi Arabia have facilitated the adoption of advanced medical technologies. These investments have led to better healthcare facilities and trained professionals, further driving the demand for embolization devices.

Middle East & Africa Embolization Devices Market Strategic Insights

Get more information on this report Request Free Sample PDF

Middle East & Africa Embolization Devices Market Segmentation Analysis

Key segments that contributed to the derivation of the Middle East & Africa embolization devices market analysis are type, application, and end user.

• Based on type, the Middle East & Africa embolization devices market is segmented into embolization coils, plugs, beads, glues, and others. The embolization coils held the largest share of the market in 2024. The embolization coils segment is further sub segmented into central application and peripheral application.
• Based on application, the Middle East & Africa embolization devices market is segmented into neurology, peripheral vascular disease, oncology, urology, and others. The neurology held the largest share of the market in 2024.
• Based on end user, the Middle East & Africa embolization devices market is segmented into hospitals, ambulatory centers, and others. The hospitals held the largest share of the market in 2024.

Middle East & Africa Embolization Devices Market Outlook

Vascular diseases, including peripheral artery disease (PAD), aneurysms, and arteriovenous malformations (AVMs), are becoming more prevalent globally. These conditions have become particularly common among geriatric populations and individuals exposed to lifestyle-related risk factors. Peripheral vascular disease (PVD) consists of PAD and venous disease.

Almost 500,000 people die worldwide due to brain aneurysms each year. Brain aneurysms are most prevalent in people from the age group of 35–60, and most aneurysms develop after the age of 40. Additionally, ruptured brain aneurysms account for 3–5% of all new strokes.

As per the World Health Organization (WHO), postpartum hemorrhage is the foremost cause of maternal mortality globally. About 14 million women experience this each year, resulting in about 70,000 maternal deaths worldwide. Additionally, as per the Institute for Functional Medicine, the prevalence of uterine fibroids has increased a predictable 78.82% in the past 30 decades, from 126.41 million to 226.05 million cases.

These clinical conditions can be effectively treated using embolization devices as these tools are designed to block abnormal or excessive blood flow within blood vessels, and this technique is preferred due to its minimally invasive nature. Embolization involves the deliberate occlusion of blood vessels to treat conditions such as aneurysms, postpartum hemorrhage, uterine fibroids, and certain types of tumors. Embolization is used to control severe bleeding after childbirth when conventional methods are ineffective, as well as blocks the blood supply to fibroids, causing them to shrink and symptoms to improve. Thus, the escalating burden of these conditions fuels the growth of the embolization devices market.

Middle East & Africa Embolization Devices Market Country Insights

Based on country, the Middle East & Africa embolization devices market comprises Saudi Arabia, South Africa, the UAE, and the Rest of Middle East & Africa. South Africa held the largest share in 2024. 

Saudi government's Vision 2030 initiative aims to enhance the healthcare sector by increasing private sector participation and investing in medical infrastructure. For instance, the Ministry of Health of Saudi Arabia announced plans to construct several hospitals across the country in 2019. Moreover, the Gulf Cooperation Council (GCC) announced plans to invest US$ 66.67 billion (SR 250 billion) in healthcare infrastructure, aiming to boost private sector participation from 40% to 65% by 2030. These efforts support the development of a more robust healthcare system, in turn fueling the adoption of advanced medical devices, including embolization technologies.

Middle East & Africa Embolization Devices Market Report Highlights

Middle East & Africa Embolization Devices Market Company Profiles

Some of the key players operating in the market include Medtronic Plc; Cook Medical Holdings LLC; Stryker Corp; Boston Scientific Corp; Terumo Corp; Johnson & Johnson; Abbott Laboratories; NeuroSafe Medical Co. Ltd; Wallaby Medical; Sirtex Medical Ltd; GEM srl; Penumbra Inc.; Balt; Lepu Medical Technology Beijing Co Ltd; INVAMED; Meril Life Sciences Pvt Ltd; Merit Medical Systems Inc; and Lifetech Scientific Corp among others. These players are adopting various strategies such as expansion, product innovation, and mergers and acquisitions to provide innovative products to their consumers and increase their market share.

Middle East & Africa Embolization Devices Market Research Methodology :

The following methodology has been followed for the collection and analysis of data presented in this report:

• Secondary Research

The research process begins with comprehensive secondary research, utilizing both internal and external sources to gather qualitative and quantitative data for each market. Commonly referenced secondary research sources include, but are not limited to:

• Company websites, annual reports, financial statements, broker analyses, and investor presentations.
• Industry trade journals and other relevant publications.
• Government documents, statistical databases, and market reports.
• News articles, press releases, and webcasts specific to companies operating in the market.

Note: All financial data included in the Company Profiles section has been standardized to USD. For companies reporting in other currencies, figures have been converted to USD using the relevant exchange rates for the corresponding year.

• Primary Research

The Insights Partners conducts a significant number of primary interviews each year with industry stakeholders and experts to validate its data analysis and gain valuable insights. These research interviews are designed to:

• Validate and refine findings from secondary research.
• Enhance the expertise and market understanding of the analysis team.
• Gain insights into market size, trends, growth patterns, competitive dynamics, and future prospects.

Primary research is conducted via email interactions and telephone interviews, encompassing various markets, categories, segments, and sub-segments across different regions. Participants typically include:

• Industry stakeholders: Vice Presidents, business development managers, market intelligence managers, and national sales managers
• External experts: Valuation specialists, research analysts, and key opinion leaders with industry-specific expertise

Middle East & Africa Embolization Devices Market Country and Regional Insights